Patents by Inventor Shabana U. Simjee

Shabana U. Simjee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11419833
    Abstract: A nasally administered liquid, including suspension and viscous liquid compositions, containing a therapeutically effective quantity of (Z)-2-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid, its salts or analogs, combined with suitable pharmaceutical ingredients, to treat epilepsy.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: August 23, 2022
    Inventors: Farzana Shaheen, Atta-ur Rahman, Muhammad I. Choudhary, Shabana U. Simjee, Zehra Batool
  • Publication number: 20210322344
    Abstract: A nasally administered liquid, including suspension and viscous liquid compositions, containing a therapeutically effective quantity of (Z)-2-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid, its salts or analogs, combined with suitable pharmaceutical ingredients, to treat epilepsy.
    Type: Application
    Filed: September 8, 2020
    Publication date: October 21, 2021
    Inventors: Farzana Shaheen, Atta-ur Rahman, Muhammad I. Choudhary, Shabana U. Simjee, Zehra Batool
  • Publication number: 20210322343
    Abstract: A nasally administered liquid, including suspension and viscous liquid compositions, containing a therapeutically effective quantity of (Z)-2-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid, its salts or analogs, combined with suitable pharmaceutical ingredients, to treat epilepsy.
    Type: Application
    Filed: April 15, 2020
    Publication date: October 21, 2021
    Inventors: Farzana Shaheen, Atta-ur Rahman, Muhammad I. Chourdhary, Shabana U. Simjee, Zehra Batool
  • Patent number: 10550155
    Abstract: This invention provides new anticancer analogs of antimicrobial peptide temporin-SHa. New analogs (SEQ ID NOs: 2-6) of temporin SHa and, two different conjugates (7 & 8) comprising of monomeric and dimeric form of SEQ ID NO 4 with cancer targeting ligand were identified as anticancer peptides.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: February 4, 2020
    Inventors: Farzana Shaheen, Muhammad Nadeem-ul-Haque, Shabana U. Simjee, Aqeel Ahmed, Zafar Ali Shah, Almas Jabeen, Muhammad Iqbal Choudhary
  • Publication number: 20190300572
    Abstract: This invention provides new anticancer analogs of antimicrobial peptide temporin-SHa. New analogs (SEQ ID NOs: 2-6) of temporin SHa and, two different conjugates (7 & 8) comprising of monomeric and dimeric form of SEQ ID NO 4 with cancer targeting ligand were identified as anticancer peptides.
    Type: Application
    Filed: March 27, 2018
    Publication date: October 3, 2019
    Inventors: Farzana Shaheen, Muhammad Nadeem-ul-Haque, Shabana U. Simjee, Aqeel Ahmed, Zafar Ali Shah, Almas Jabeen, Muhammad Iqbal Choudhary